-
Product Insights
NewCardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewHuman Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Sector Analysis
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Report Overview The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market size was $3.79 billion in 2023. The market is expected to grow at a CAGR of less than 1% during 2023-2033. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic. However, if left untreated they can cause pelvic inflammatory disease (PID), which, in turn, can lead to additional complications such as...
-
Sector Analysis
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
PCR Systems Market Report Overview The PCR Systems market size was $737.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Polymerase Chain Reaction (PCR) systems are used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. PCR Systems Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the PCR Systems Market Forecast Download a Free...
-
Sector Analysis
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.38 billion in 2023 and is expected to grow at a CAGR of more than 4% during 2023-2033. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. They are typically offered in modular increments, which can operate independently or simultaneously as a unit. Immunochemistry Analyzers Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into...
-
Sector Analysis
HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
HER2 tests Market Report Overview The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH). HER2 tests Market Outlook 2023-2033...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. Severe Acute Respiratory Syndrome Coronavirus, SARS‐CoV‐2, a novel coronavirus from the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has spread worldwide leading the World Health Organization (WHO) to declare a pandemic. The disease caused by SARS‐CoV‐2, coronavirus disease 2019 (COVID‐19), presents flu‐like symptoms that can become serious in high‐risk individuals, is a rapidly evolving situation across the globe, and has...
-
Sector Analysis
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Helicobacter Pylori Tests Market Report Overview The Helicobacter Pylori Tests market size was valued at $338.5 million in 2023. The Helicobacter Pylori Tests market will grow at a CAGR of more than 2% from 2023 to 2033. H. pylori has been recognized as a Class I carcinogen by the International Agency for Research on Cancer and as one of the strongest known risk factors for gastric malignancies such as peptic ulcer disease, gastric MALT lymphoma and gastric cancer as 89%...
-
Product Insights
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Market Report Overview Nucleic Acid Amplification Tests (NAAT) involve the amplification of specific nucleic acid sequences of the SARS-CoV-2 virus by targeting specific nucleic acid sequences. NAAT exhibits better sensitivity in comparison to other antigen identification methods. The COVID-19 NAATs pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical...